CIK 0001850270 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in E9 · fiscal year ends 12/31
| FY2025 | FY2023 | FY2022 | |
|---|---|---|---|
| Net income (USD) | -69.0 M | -55.1 M | |
| Diluted EPS (USD/shares) | -0.23 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-08-20 | 4 | 4 | 2026-08-18 |
| 2026-08-18 | 144 | 144 | |
| 2026-08-18 | 144 | 144 | |
| 2026-08-12 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-10 | 8-K | 8-K items 2.02,9.01 | 2026-08-10 |
| 2026-08-10 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-06 | 4 | 4 | 2026-08-04 |
| 2026-07-06 | 4 | 4 | 2026-07-01 |
| 2026-06-15 | 4 | 4 | 2026-06-12 |
| 2026-06-10 | 3 | 3 | 2026-06-01 |
| 2026-05-29 | 4 | 4 | 2026-05-28 |
| 2026-05-29 | 4 | 4 | 2026-05-28 |
| 2026-05-29 | 4 | 4 | 2026-05-28 |
| 2026-05-29 | 4 | 4 | 2026-05-28 |
| 2026-05-29 | 4 | 4 | 2026-05-28 |
| 2026-05-29 | 4 | 4 | 2026-05-28 |
| 2026-05-29 | 4 | 4 | 2026-05-28 |
| 2026-05-29 | 8-K | 8-K items 5.07 | 2026-05-28 |
| 2026-05-15 | 8-K | 8-K items 2.02,7.01,8.01,9.01 | 2026-05-15 |
| 2026-05-15 | 10-Q | 10-Q | 2026-03-31 |
| 2026-04-30 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-04-30 | 4 | FORM 4 | 2026-04-28 |
| 2026-04-17 | ARS | ARS | 2025-12-31 |
| 2026-04-17 | DEFA14A | DEFA14A | |
| 2026-04-17 | DEF 14A | DEF 14A | 2026-05-28 |
Forms on file (last 1,000): 4 124, 8-K 62, 3 26, DEFA14A 22, 10-Q 16, 424B3 15, 144 11, SC 13G/A 11. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=PROK (0.002 USD), /gw/filings/filings?ticker=PROK&form=8-K, /gw/filings/facts?ticker=PROK&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange